ANDA 77408, held by Actavis Labs Fl Inc. Levetiracetam.
As of Nov 15, 2026, ANDA 77408 (Levetiracetam), held by Actavis Labs Fl Inc, was first approved by FDA on Mar 2, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 2, 2009 | Original application | Approved | None posted |
| Levetiracetam250MG · tablet;oral | Levetiracetam | Discontinued |
| Levetiracetam500MG · tablet;oral | Levetiracetam | Discontinued |
| Levetiracetam750MG · tablet;oral | Levetiracetam | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
